ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -100.0% | 1,693 | -81.3% | 0.00% | – |
| Q2 2022 | $17,000 | +21.4% | 9,070 | +11.8% | 0.00% | – |
| Q1 2022 | $14,000 | +1300.0% | 8,113 | +472.5% | 0.00% | – |
| Q4 2021 | $1,000 | -99.7% | 1,417 | -99.2% | 0.00% | – |
| Q3 2021 | $291,000 | -0.7% | 183,196 | 0.0% | 0.00% | – |
| Q2 2021 | $293,000 | -2.0% | 183,196 | +7.5% | 0.00% | -100.0% |
| Q1 2021 | $299,000 | – | 170,364 | +41050.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 414 | -99.6% | 0.00% | -100.0% |
| Q2 2020 | $335,000 | +335.1% | 114,363 | +327.6% | 0.00% | – |
| Q1 2020 | $77,000 | +285.0% | 26,748 | +434.7% | 0.00% | – |
| Q4 2019 | $20,000 | – | 5,002 | +1661.3% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 284 | -95.0% | 0.00% | – |
| Q3 2018 | $35,000 | – | 5,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |